Literature DB >> 24939607

Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats.

Kazuhide Hamada1, Yoichi Miura, Naoki Toma, Keiichi Miyamoto, Kyoko Imanaka-Yoshida, Satoshi Matsushima, Toshimichi Yoshida, Waro Taki, Hidenori Suzuki.   

Abstract

The aims of this study were to develop a new coil, gellan sulfate core platinum coil (GSCC), that delivers tenascin-C (TNC) to an aneurysm (GSCC-TNC) and to evaluate the effects on intra-aneurysmal organization. We performed in vitro adsorption tests of TNC to gellan sulfate (GS). GSCC-TNC was produced by immersing GSCC in TNC solution under the following conditions (TNC concentration 10, 50, or 100 μg/mL; TNC immersion time 15, 30, or 60 min) by monitoring intra-aneurysmal organization in a rat blind-ended aneurysm model. In addition, 20 rats randomly underwent implantation of a platinum coil or the GSCC-TNC produced under optimum conditions into an aneurysm, whose organization effects were compared in a blind fashion at 2 weeks post-surgery. GS demonstrated a high affinity to TNC in a dose-dependent fashion (affinity constant = 1.79 × 10(10) (M(-1))). GSCC immersed in 10 μg/mL of TNC solution for 30 and 60 min induced similar and better organization of aneurysmal cavity compared with that for 15 min (the ratio of the organized areas in an aneurysmal cavity-15 min, 27.2 ± 11.8 %; 30 min, 75.6 ± 11.9 %; 60 min, 82.6 ± 19.7 %, respectively) with the preservation of the aneurysmal wall structure, while higher TNC concentrations caused the destruction of the aneurysmal wall. GSCC-TNC produced under 10 μg/mL of TNC solution for 30 min showed a significantly better organization of aneurysms compared with bare platinum coils in rats. A newly developed coil, GSCC-TNC, may be effective for improving intra-aneurysmal organization after coil embolization.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939607     DOI: 10.1007/s12975-014-0352-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  27 in total

1.  Matrix detachable coils for the endovascular treatment of intracranial aneurysms: analysis of early angiographic and clinical outcomes.

Authors:  Christian A Taschner; Xavier Leclerc; Henda Rachdi; Alexander Maia Barros; Jean-Pierre Pruvo
Journal:  Stroke       Date:  2005-09-08       Impact factor: 7.914

2.  Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.

Authors:  Ilunga Kalembeyi; Hiroyasu Inada; Rika Nishiura; Kyoko Imanaka-Yoshida; Teruyo Sakakura; Toshimichi Yoshida
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

Review 3.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

4.  Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

Authors:  Kiyohito Yamamoto; Koji Onoda; Yasuhiro Sawada; Kazuya Fujinaga; Kyoko Imanaka-Yoshida; Hideto Shimpo; Toshimichi Yoshida; Isao Yada
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

5.  Gross and microscopic histopathological findings in aneurysms of the human brain treated with Guglielmi detachable coils.

Authors:  G Bavinzski; V Talazoglu; M Killer; B Richling; A Gruber; C E Gross; H Plenk
Journal:  J Neurosurg       Date:  1999-08       Impact factor: 5.115

6.  Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats.

Authors:  Masato Shiba; Masashi Fujimoto; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Waro Taki; Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-02-01       Impact factor: 6.829

7.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

8.  Tenascin-C-coated platinum coils for acceleration of organization of cavities and reduction of lumen size in a rat aneurysm model.

Authors:  Naoki Toma; Kyoko Imanaka-Yoshida; Taku Takeuchi; Satoshi Matsushima; Hiroo Iwata; Toshimichi Yoshida; Waro Taki
Journal:  J Neurosurg       Date:  2005-10       Impact factor: 5.115

9.  Embolization of intracranial aneurysms with second-generation Matrix-2 detachable coils: mid-term and long-term results.

Authors:  Sameer A Ansari; Eric J Dueweke; Yassine Kanaan; Neeraj Chaudhary; Dheeraj Gandhi; B Gregory Thompson; Joseph J Gemmete
Journal:  J Neurointerv Surg       Date:  2011-02-18       Impact factor: 5.836

10.  EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells.

Authors:  Kurt Wallner; Chen Li; Prediman K Shah; Kai-Jin Wu; Stephen M Schwartz; Behrooz G Sharifi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

View more
  5 in total

1.  What is early brain injury?

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-12-16       Impact factor: 6.829

Review 2.  Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering.

Authors:  Hannah A Strobel; Elisabet I Qendro; Eben Alsberg; Marsha W Rolle
Journal:  Front Pharmacol       Date:  2018-11-21       Impact factor: 5.810

Review 3.  The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 4.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.

Authors:  Ken-Ichi Matsumoto; Hiroki Aoki
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

5.  Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective?

Authors:  Hidenori Suzuki; Fumihiro Kawakita
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.